{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:27:36Z","timestamp":1790839656951,"version":"4.1.0"},"reference-count":156,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.psychres.2020.113409","type":"journal-article","created":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T11:37:46Z","timestamp":1597750666000},"page":"113409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"special_numbering":"C","title":["Galantamine-Memantine combination in the treatment of Alzheimer's disease and beyond"],"prefix":"10.1016","volume":"293","author":[{"given":"Maju Mathew","family":"Koola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7702","key":"10.1016\/j.psychres.2020.113409_bib0001","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/d41586-018-04930-7","article-title":"Is \u2018friendly fire\u2019 in the brain provoking Alzheimer\u2019s disease?","volume":"556","author":"Abbott","year":"2018","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.psychres.2020.113409_bib0002","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1212\/WNL.0b013e318207b1b9","article-title":"Report of the task force on designing clinical trials in early (predementia) AD","volume":"76","author":"Aisen","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.psychres.2020.113409_bib0003","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1749-6632.1995.tb17464.x","article-title":"Nicotinic receptor function in the mammalian central nervous system","volume":"757","author":"Albuquerque","year":"1995","journal-title":"Ann. N Y Acad. Sci."},{"issue":"2","key":"10.1016\/j.psychres.2020.113409_bib0004","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1176\/ajp.154.2.165","article-title":"Association of premorbid intellectual function with cerebral metabolism in Alzheimer's disease: implications for the cognitive reserve hypothesis","volume":"154","author":"Alexander","year":"1997","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.psychres.2020.113409_bib0005","first-page":"459","article-title":"Alzheimer's disease facts and figures","volume":"12","year":"2016","journal-title":"Alzheimers Dement. 2016"},{"issue":"4","key":"10.1016\/j.psychres.2020.113409_bib0006","first-page":"325","article-title":"Alzheimer's disease facts and figures","volume":"13","year":"2017","journal-title":"Alzheimer's Dement. 2017"},{"issue":"19","key":"10.1016\/j.psychres.2020.113409_bib0007","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1111\/bph.13956","article-title":"Pharmacology of cognition: a panacea for neuropsychiatric disease?","volume":"174","author":"Bailey","year":"2017","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.psychres.2020.113409_bib0008","doi-asserted-by":"crossref","first-page":"9324","DOI":"10.1038\/s41598-019-45796-7","article-title":"Facilitation and inhibition of firing activity and N-methyl-d-aspartate-evoked responses of CA1 hippocampal pyramidal cells by alpha7 nicotinic acetylcholine receptor selective compounds in vivo","volume":"9","author":"Bali","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.psychres.2020.113409_bib0009","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fphar.2019.00073","article-title":"Cognitive enhancer effects of low memantine doses are facilitated by an alpha7 nicotinic acetylcholine receptor agonist in scopolamine-induced amnesia in rats","volume":"10","author":"Bali","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.psychres.2020.113409_bib0010","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.nlm.2010.02.001","article-title":"Memantine ameliorates scopolamine-induced amnesia in chicks trained on taste-avoidance learning","volume":"93","author":"Barber","year":"2010","journal-title":"Neurobiol. Learn. Mem."},{"issue":"2","key":"10.1016\/j.psychres.2020.113409_bib0011","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s00259-019-04461-x","article-title":"In vivo imaging of synaptic loss in Alzheimer's disease with [18F]UCB-H positron emission tomography","volume":"47","author":"Bastin","year":"2020","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"1","key":"10.1016\/j.psychres.2020.113409_bib0012","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jalz.2012.01.007","article-title":"Fire in the ashes: can failed Alzheimer's disease drugs succeed with second chances?","volume":"9","author":"Becker","year":"2013","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.psychres.2020.113409_bib0013","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3389\/fncel.2015.00178","article-title":"Alternative kynurenic acid synthesis routes studied in the rat cerebellum","volume":"9","author":"Blanco Ayala","year":"2015","journal-title":"Front. Cell Neurosci."},{"issue":"4","key":"10.1016\/j.psychres.2020.113409_bib0014","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1254\/jphs.12166SC","article-title":"Synergistic effects of galantamine and memantine in attenuating scopolamine-induced amnesia in mice","volume":"120","author":"Busquet","year":"2012","journal-title":"J. Pharmacol. Sci."},{"issue":"14","key":"10.1016\/j.psychres.2020.113409_bib0015","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1017\/S0033291719001995","article-title":"An update on the efficacy of anti-inflammatory agents for patients with schizophrenia: a meta-analysis","volume":"49","author":"\u00c7akici","year":"2019","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psychres.2020.113409_bib0016","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fnins.2014.00012","article-title":"Kynurenines in CNS disease: regulation by inflammatory cytokines","volume":"8","author":"Campbell","year":"2014","journal-title":"Front. Neurosci."},{"issue":"5","key":"10.1016\/j.psychres.2020.113409_bib0017","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nrd2036","article-title":"Integrative pharmacology and drug discovery\u2013is the tide finally turning?","volume":"5","author":"Collis","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.psychres.2020.113409_bib0018","doi-asserted-by":"crossref","DOI":"10.1117\/1.NPh.3.4.041811","article-title":"Review on the role of AMPA receptor nano-organization and dynamic in the properties of synaptic transmission","volume":"3","author":"Compans","year":"2016","journal-title":"Neurophotonics"},{"issue":"3","key":"10.1016\/j.psychres.2020.113409_bib0019","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10522-020-09860-4","article-title":"Alzheimer\u2019s disease: targeting the glutamatergic system","volume":"21","author":"Conway","year":"2020","journal-title":"Biogerontology"},{"issue":"6","key":"10.1016\/j.psychres.2020.113409_bib0020","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nrd4309","article-title":"Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework","volume":"13","author":"Cook","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.psychres.2020.113409_bib0021","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2967\/jnumed.119.230979","article-title":"High availability of the \u03b17 nicotinic acetylcholine receptor in brains of individuals with mild cognitive impairment: a pilot study using 18F-ASEM PET","volume":"61","author":"Coughlin","year":"2020","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.psychres.2020.113409_bib0022","doi-asserted-by":"crossref","first-page":"e777","DOI":"10.1038\/tp.2016.40","article-title":"In vivo markers of inflammatory response in recent-onset schizophrenia: a combined study using [(11)C]DPA-713 PET and analysis of CSF and plasma","volume":"6","author":"Coughlin","year":"2016","journal-title":"Transl. Psychiatry"},{"issue":"5134","key":"10.1016\/j.psychres.2020.113409_bib0023","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1126\/science.7901908","article-title":"Oxidative stress, glutamate, and neurodegenerative disorders","volume":"262","author":"Coyle","year":"1993","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.psychres.2020.113409_bib0024","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer's disease","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.psychres.2020.113409_bib0025","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pnpbp.2015.08.001","article-title":"The 15q13.3 deletion syndrome: deficient \u03b1(7)-containing nicotinic acetylcholine receptor-mediated neurotransmission in the pathogenesis of neurodevelopmental disorders","volume":"64","author":"Deutsch","year":"2016","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2020.113409_bib0026","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.tips.2014.12.002","article-title":"Nicotinic ACh receptors as therapeutic targets in CNS disorders","volume":"36","author":"Dineley","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.psychres.2020.113409_bib0027","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejphar.2018.02.047","article-title":"Functional characterization of \u03b17 nicotinic acetylcholine and NMDA receptor signaling in SH-SY5Y neuroblastoma cells in an ERK phosphorylation assay","volume":"826","author":"Elnagar","year":"2018","journal-title":"Eur. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.psychres.2020.113409_bib0028","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.2967\/jnumed.109.062265","article-title":"Initial evaluation of 11C-DPA-713, a novel TSPO PET ligand, in humans","volume":"50","author":"Endres","year":"2009","journal-title":"J. Nucl. Med."},{"issue":"6","key":"10.1016\/j.psychres.2020.113409_bib0029","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1177\/1971400919857544","article-title":"Changes in metabolites in the brain of patients with fibromyalgia after treatment with an NMDA receptor antagonist","volume":"32","author":"Fayed","year":"2019","journal-title":"Neuroradiol. J."},{"issue":"3","key":"10.1016\/j.psychres.2020.113409_bib0030","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0920-1211(02)00216-4","article-title":"alpha-[11C]-Methyl-l-tryptophan PET identifies the epileptogenic tuber and correlates with interictal spike frequency","volume":"52","author":"Fedi","year":"2003","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.psychres.2020.113409_bib0031","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.trci.2019.09.019","article-title":"Prevention of Alzheimer's disease by treating mild cognitive impairment with combinations chosen from eight available drugs","volume":"5","author":"Fessel","year":"2019","journal-title":"Alzheimers Dement. (N Y)"},{"issue":"348","key":"10.1016\/j.psychres.2020.113409_bib0032","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf6667","article-title":"Imaging synaptic density in the living human brain","volume":"8","author":"Finnema","year":"2016","journal-title":"Sci. Transl. Med."},{"issue":"12","key":"10.1016\/j.psychres.2020.113409_bib0033","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.bcp.2011.01.021","article-title":"Developing predictive CSF biomarkers-a challenge critical to success in Alzheimer's disease and neuropsychiatric translational medicine","volume":"81","author":"Flood","year":"2011","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.psychres.2020.113409_bib0034","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1021\/acs.jmedchem.8b00714","article-title":"Positron Emission Tomography (PET) Ligand Development for Ionotropic Glutamate Receptors: challenges and Opportunities for Radiotracer Targeting N-Methyl-d-aspartate (NMDA), \u03b1-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA), and Kainate Receptors","volume":"62","author":"Fu","year":"2019","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.psychres.2020.113409_bib0035","doi-asserted-by":"crossref","first-page":"164","DOI":"10.14283\/jpad.2019.12","article-title":"Combination Therapy for Alzheimer\u2019s Disease: perspectives of the EU\/US CTAD Task Force","volume":"6","author":"Gauthier","year":"2019","journal-title":"J. Prev. Alzheimers Dis."},{"issue":"7 Suppl 1","key":"10.1016\/j.psychres.2020.113409_bib0036","article-title":"Pharmacology of acetylcholinesterase inhibitors and N-methyl-d-aspartate receptors for combination therapy in the treatment of Alzheimer\u2019s disease","volume":"46","author":"Geerts","year":"2006","journal-title":"J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.psychres.2020.113409_bib0037","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/alz.12082","article-title":"Learning from amyloid trials in Alzheimer's disease. A virtual patient analysis using a quantitative systems pharmacology approach","volume":"16","author":"Geerts","year":"2020","journal-title":". Alzheimers Dement."},{"key":"10.1016\/j.psychres.2020.113409_bib0038","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jpsychires.2018.07.006","article-title":"The past and future of novel, non-dopamine-2 receptor therapeutics for schizophrenia: a critical and comprehensive review","volume":"108","author":"Girgis","year":"2019","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psychres.2020.113409_bib0039","article-title":"The brain cognitive reserve hypothesis: a review with emphasis on the contribution of nuclear medicine neuroimaging techniques","author":"Giovacchini","year":"2020","journal-title":"J. Cell Physiol."},{"issue":"1","key":"10.1016\/j.psychres.2020.113409_bib0040","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2174\/1570159X14666160225154812","article-title":"d-cycloserine in Schizophrenia: new Strategies for Improving Clinical Outcomes by Enhancing Plasticity","volume":"15","author":"Goff","year":"2017","journal-title":"Curr. Neuropharmacol."},{"issue":"7 Suppl 1","key":"10.1016\/j.psychres.2020.113409_bib0041","article-title":"Rationale for combination therapy with galantamine and memantine in Alzheimer's disease","volume":"46","author":"Grossberg","year":"2006","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.psychres.2020.113409_bib0042","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuropharm.2016.03.021","article-title":"The need for new approaches in CNS drug discovery: why drugs have failed, and what can be done to improve outcomes","volume":"120","author":"Gribkoff","year":"2017","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.psychres.2020.113409_bib0043","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.bbi.2005.04.005","article-title":"Peripheral immune activation by lipopolysaccharide decreases neurotrophins in the cortex and hippocampus in rats","volume":"20","author":"Guan","year":"2006","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.psychres.2020.113409_bib0044","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13195-016-0214-x","article-title":"Effect of Concomitant Use of Memantine on Mortality and Efficacy Outcomes of Galantamine-Treated Patients With Alzheimer\u2019s Disease: post-Hoc Analysis of a Randomized Placebo-Controlled Study","volume":"8","author":"Hager","year":"2016","journal-title":"Alzheimers Res. Ther."},{"issue":"1","key":"10.1016\/j.psychres.2020.113409_bib0045","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3233\/ADR-190143","article-title":"Role of fluid biomarkers and PET imaging in early diagnosis and its clinical implication in the management of Alzheimer's Disease","volume":"4","author":"Hameed","year":"2020","journal-title":"J. Alzheimers Dis. Rep."},{"key":"10.1016\/j.psychres.2020.113409_bib0046","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.schres.2017.06.040","article-title":"Interactive effects of an N-methyl-d-aspartate receptor antagonist and a nicotinic acetylcholine receptor agonist on mismatch negativity: implications for schizophrenia","volume":"191","author":"Hamilton","year":"2018","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.psychres.2020.113409_bib0047","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0166-2236(02)00040-1","article-title":"The Yin and Yang of NMDA receptor signalling","volume":"26","author":"Hardingham","year":"2003","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.psychres.2020.113409_bib0048","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1042\/BST0371147","article-title":"Coupling of the NMDA receptor to neuroprotective and neurodestructive events","volume":"37","author":"Hardingham","year":"2009","journal-title":"Biochem. Soc. Trans."},{"issue":"1","key":"10.1016\/j.psychres.2020.113409_bib0049","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bbrc.2019.08.025","article-title":"Neuroprotective effects of memantine via enhancement of autophagy","volume":"518","author":"Hirano","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.psychres.2020.113409_bib0050","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1046\/j.1460-9568.1998.00208.x","article-title":"Interference with cellular energy metabolism reduces kynurenic acid formation in rat brain slices: reversal by lactate and pyruvate","volume":"10","author":"Hodgkins","year":"1998","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.psychres.2020.113409_bib0051","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","article-title":"National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease","volume":"8","author":"Hyman","year":"2012","journal-title":"Alzheimers Dement."},{"issue":"4","key":"10.1016\/j.psychres.2020.113409_bib0052","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1755-5949.2009.00090.x","article-title":"Galantamine-ER for cognitive dysfunction in bipolar disorder and correlation with hippocampal neuronal viability: a proof-of-concept study","volume":"15","author":"Iosifescu","year":"2009","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.psychres.2020.113409_bib0053","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejphar.2017.02.001","article-title":"Memantine reduces the production of amyloid-\u03b2 peptides through modulation of amyloid precursor protein trafficking","volume":"798","author":"Ito","year":"2017","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.psychres.2020.113409_bib0055","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1023\/A:1027376230898","article-title":"Cholinergic neurotransmission and synaptic plasticity concerning memory processing","volume":"22","author":"Jerusalinsky","year":"1997","journal-title":"Neurochem. Res."},{"issue":"1","key":"10.1016\/j.psychres.2020.113409_bib0056","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/s12035-014-9053-6","article-title":"Mechanism of oxidative stress and synapse dysfunction in the pathogenesis of Alzheimer\u2019s Disease: understanding the therapeutics strategies","volume":"53","author":"Kamat","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.psychres.2020.113409_bib0057","unstructured":"Kindler J., Lim C.K., Weickert C.S., Boerrigter D., Galletly C., Liu D., Jacobs K.R., Balzan R., Bruggemann J., O'Donnell M., Lenroot R., Guillemin G.J., Weickert T.W. Dysregulation of kynurenine metabolism is related to proinflammatory cytokines, attention, and prefrontal cortex volume in schizophrenia. Mol. Psychiatry. In press."},{"key":"10.1016\/j.psychres.2020.113409_bib0058","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.nucmedbio.2017.05.003","article-title":"Synthesis, radiolabeling and preclinical evaluation of a [11C]GMOM derivative as PET radiotracer for the ion channel of the N-methyl-d-aspartate receptor","volume":"51","author":"Klein","year":"2017","journal-title":"Nucl. Med. Biol."},{"issue":"3","key":"10.1016\/j.psychres.2020.113409_bib0059","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1177\/0271678X17699223","article-title":"11C-DPA-713 has much greater specific binding to translocator protein 18\u2009kDa (TSPO) in human brain than 11C-(R)-PK11195","volume":"38","author":"Kobayashi","year":"2018","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.psychres.2020.113409_bib0060","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s40473-019-00174-5","article-title":"Galantamine-Memantine Combination as an Antioxidant Treatment for Schizophrenia","volume":"6","author":"Koola","year":"2019","journal-title":"Curr. Behav. Neurosci. Rep."},{"issue":"2","key":"10.1016\/j.psychres.2020.113409_bib0061","first-page":"57","article-title":"Galantamine-memantine combination superior to donepezil-memantine combination in Alzheimer's disease: critical dissection with an emphasis on kynurenic acid and mismatch negativity","volume":"5","author":"Koola","year":"2018","journal-title":"J. Geriatr. Care Res."},{"key":"10.1016\/j.psychres.2020.113409_bib0062","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.scog.2017.11.001","article-title":"Galantamine-memantine combination effective in dementia: translate to dementia praecox?","volume":"12","author":"Koola","year":"2018","journal-title":"Schizophr. Res. Cogn."},{"key":"10.1016\/j.psychres.2020.113409_bib0063","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ajp.2019.02.007","article-title":"Antipsychotic-minocycline-acetylcysteine combination for positive, cognitive, and negative symptoms of schizophrenia","volume":"40","author":"Koola","year":"2019","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.psychres.2020.113409_bib0064","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ajp.2017.11.008","article-title":"Galantamine and memantine combination for cognition: enough or more than enough to translate from murines and macaques to men with schizophrenia?","volume":"42","author":"Koola","year":"2019","journal-title":"Asian J. Psychiatr."},{"issue":"2","key":"10.1016\/j.psychres.2020.113409_bib0065","article-title":"Galantamine-memantine combination for cognitive impairments due to electroconvulsive therapy, traumatic brain injury, and neurologic and psychiatric disorders: kynurenic acid and mismatch negativity target engagement","volume":"20","author":"Koola","year":"2018","journal-title":"Prim. Care Companion CNS Disord."},{"issue":"3","key":"10.1016\/j.psychres.2020.113409_bib0066","first-page":"134","article-title":"Potential role of antipsychotic-galantamine-memantine combination in the treatment of positive, cognitive, and negative symptoms of schizophrenia","volume":"4","author":"Koola","year":"2018","journal-title":"Mol. Neuropsychiatry"},{"key":"10.1016\/j.psychres.2020.113409_bib0067","unstructured":"Koola M.M., Looney S.W., Hong H., Pillai A., Hou W. Meta-analysis of randomized controlled trials of galantamine in schizophrenia: significant cognitive enhancement. Psychiatry Res. in press."},{"key":"10.1016\/j.psychres.2020.113409_bib0068","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.neuropharm.2014.03.004","article-title":"A systemically-available kynurenine aminotransferase II (KAT II) inhibitor restores nicotine-evoked glutamatergic activity in the cortex of rats","volume":"82","author":"Koshy Cherian","year":"2014","journal-title":"Neuropharmacology"},{"issue":"32","key":"10.1016\/j.psychres.2020.113409_bib0069","doi-asserted-by":"crossref","first-page":"10592","DOI":"10.1523\/JNEUROSCI.1107-14.2014","article-title":"Reduction of brain kynurenic acid improves cognitive function","volume":"34","author":"Kozak","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.psychres.2020.113409_bib0070","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.bbr.2012.12.053","article-title":"Peripheral administration of d-cycloserine rescues memory consolidation following bacterial endotoxin exposure","volume":"243","author":"Kranjac","year":"2013","journal-title":"Behav. Brain Res."},{"issue":"12","key":"10.1016\/j.psychres.2020.113409_bib0071","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1021\/acschemneuro.0c00135","article-title":"Synthesis and preclinical evaluation of 6-[18F]Fluorine-Alpha-Methyl-l-Tryptophan, a novel PET tracer for measuring tryptophan uptake","volume":"11","author":"Krasikova","year":"2020","journal-title":"ACS Chem. Neurosci."},{"issue":"3","key":"10.1016\/j.psychres.2020.113409_bib0072","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/JCP.0000000000000109","article-title":"The effects of add-on low-dose memantine on cytokine levels in bipolar II depression: a 12-week double-blind, randomized controlled trial","volume":"34","author":"Lee","year":"2014","journal-title":"J. Clin. Psychopharmacol."},{"issue":"9","key":"10.1016\/j.psychres.2020.113409_bib0073","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1007\/s00259-019-04357-w","article-title":"Synthesis and in vivo evaluation of [18F]UCB-J for PET imaging of synaptic vesicle glycoprotein 2A (SV2A)","volume":"46","author":"Li","year":"2019","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.psychres.2020.113409_bib0074","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1756-6606-6-58","article-title":"\u03b17nAchR\/NMDAR coupling affects NMDAR function and object recognition","volume":"6","author":"Li","year":"2013","journal-title":"Mol. Brain"},{"key":"10.1016\/j.psychres.2020.113409_bib0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135091","article-title":"Memantine ameliorates tau protein deposition and secondary damage in the ipsilateral thalamus and sensory decline following focal cortical infarction in rats","volume":"731","author":"Liang","year":"2020","journal-title":"Neurosci. Lett."},{"issue":"6","key":"10.1016\/j.psychres.2020.113409_bib0076","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1136\/jnnp-2014-308577","article-title":"CSF lactate levels, \u03c4 proteins, cognitive decline: a dynamic relationship in Alzheimer's disease","volume":"86","author":"Liguori","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"38","key":"10.1016\/j.psychres.2020.113409_bib0077","doi-asserted-by":"crossref","first-page":"16661","DOI":"10.1073\/pnas.1007397107","article-title":"Axonal \u03b17 nicotinic ACh receptors modulate presynaptic NMDA receptor expression and structural plasticity of glutamatergic presynaptic boutons","volume":"107","author":"Lin","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.psychres.2020.113409_bib0078","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.nbd.2013.11.021","article-title":"Cortical synaptic NMDA receptor deficits in \u03b17 nicotinic acetylcholine receptor gene deletion models: implications for neuropsychiatric diseases","volume":"63","author":"Lin","year":"2014","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.psychres.2020.113409_bib0079","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12974-018-1141-5","article-title":"Galantamine improves cognition, hippocampal inflammation, and synaptic plasticity impairments induced by lipopolysaccharide in mice","volume":"15","author":"Liu","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.psychres.2020.113409_bib0080","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3389\/fnmol.2019.00198","article-title":"Secreted amyloid precursor protein-alpha promotes arc protein synthesis in hippocampal neurons","volume":"12","author":"Livingstone","year":"2019","journal-title":"Front. Mol. Neurosci."},{"issue":"2","key":"10.1016\/j.psychres.2020.113409_bib0081","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/brb3.118","article-title":"Galantamine potentiates the neuroprotective effect of memantine against NMDA-induced excitotoxicity","volume":"3","author":"Lopes","year":"2013","journal-title":"Brain Behav."},{"key":"10.1016\/j.psychres.2020.113409_bib0082","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.brainres.2008.11.095","article-title":"Effects of memantine and galantamine given separately or in association, on memory and hippocampal neuronal loss after transient global cerebral ischemia in gerbils","volume":"1254","author":"Lorrio","year":"2009","journal-title":"Brain Res."},{"issue":"22","key":"10.1016\/j.psychres.2020.113409_bib0083","doi-asserted-by":"crossref","first-page":"7651","DOI":"10.1523\/JNEUROSCI.6246-11.2012","article-title":"Glutamatergic synapse formation is promoted by \u03b17-containing nicotinic acetylcholine receptors","volume":"32","author":"Lozada","year":"2012","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.psychres.2020.113409_bib0084","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.ntt.2011.07.002","article-title":"On the antioxidant properties of kynurenic acid: free radical scavenging activity and inhibition of oxidative stress","volume":"33","author":"Lugo-Huitr\u00f3n","year":"2011","journal-title":"Neurotoxicol. Teratol."},{"issue":"1","key":"10.1016\/j.psychres.2020.113409_bib0085","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.nlm.2010.04.004","article-title":"Inhibitory avoidance memory deficit induced by scopolamine: interaction of cholinergic and glutamatergic systems in the ventral tegmental area","volume":"94","author":"Mahmoodi","year":"2010","journal-title":"Neurobiol. Learn. Mem."},{"issue":"1","key":"10.1016\/j.psychres.2020.113409_bib0086","doi-asserted-by":"crossref","first-page":"96","DOI":"10.2967\/jnumed.119.228080","article-title":"Characterization of 3 PET tracers for Quantification of Mitochondrial and Synaptic function in Healthy Human Brain: 18F-BCPP-EF, 11C-SA-4503, 11C-UCB-J","volume":"61","author":"Mansur","year":"2020","journal-title":"J. Nucl. Med."},{"issue":"4","key":"10.1016\/j.psychres.2020.113409_bib0087","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.mcn.2006.08.011","article-title":"BDNF up-regulates alpha7 nicotinic acetylcholine receptor levels on subpopulations of hippocampal interneurons","volume":"33","author":"Massey","year":"2006","journal-title":"Mol. Cell. Neurosci."},{"issue":"3","key":"10.1016\/j.psychres.2020.113409_bib0088","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3233\/JAD-143084","article-title":"Combination therapy of cholinesterase inhibitor (donepezil or galantamine) plus memantine in the okayama memantine study","volume":"45","author":"Matsuzono","year":"2015","journal-title":"J. Alzheimers Dis."},{"issue":"2","key":"10.1016\/j.psychres.2020.113409_bib0089","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-2125.2011.04085.x","article-title":"Positron emission tomography molecular imaging for drug development","volume":"73","author":"Matthews","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.psychres.2020.113409_bib0090","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.neuroimage.2016.12.038","article-title":"Test-retest reproducibility of quantitative binding measures of [11C]Ro15-4513, a PET ligand for GABAA receptors containing alpha5 subunits","volume":"152","author":"McGinnity","year":"2017","journal-title":"Neuroimage"},{"issue":"6","key":"10.1016\/j.psychres.2020.113409_bib0091","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/ana.20100","article-title":"Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum","volume":"55","author":"Mesulam","year":"2004","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.psychres.2020.113409_bib0092","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/14756366.2018.1443326","article-title":"Profiling donepezil template into multipotent hybrids with antioxidant properties","volume":"33","author":"Mezeiova","year":"2018","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"2","key":"10.1016\/j.psychres.2020.113409_bib0093","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/mp.2016.187","article-title":"Blockade of the KATP channel Kir6.2 by memantine represents a novel mechanism relevant to Alzheimer's disease therapy","volume":"23","author":"Moriguchi","year":"2018","journal-title":"Mol. Psychiatry"},{"issue":"6","key":"10.1016\/j.psychres.2020.113409_bib0094","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/nn.4018","article-title":"Three dimensions of the amyloid hypothesis: time, space and 'wingmen'","volume":"18","author":"Musiek","year":"2015","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.psychres.2020.113409_bib0095","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bbrc.2017.04.155","article-title":"Successful metformin treatment of insulin resistance is associated with down-regulation of the kynurenine pathway","volume":"488","author":"Muzik","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.psychres.2020.113409_bib0096","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.pnpbp.2013.08.008","article-title":"Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis","volume":"48","author":"Myint","year":"2014","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.psychres.2020.113409_bib0097","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2967\/jnumed.115.168179","article-title":"Synthesis and Preclinical Evaluation of 11C-UCB-J as a PET Tracer for Imaging the Synaptic Vesicle Glycoprotein 2A in the Brain","volume":"57","author":"Nabulsi","year":"2016","journal-title":"J. Nucl. Med."},{"issue":"1","key":"10.1016\/j.psychres.2020.113409_bib0098","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170829","article-title":"Possible Signaling Pathways Mediating Neuronal Calcium Sensor-1-Dependent Spatial Learning and Memory in Mice","volume":"12","author":"Nakamura","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.psychres.2020.113409_bib0099","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1536012118792317","article-title":"Emerging PET Radiotracers and Targets for Imaging of Neuroinflammation in Neurodegenerative Diseases: outlook Beyond TSPO","volume":"17","author":"Narayanaswami","year":"2018","journal-title":"Mol. Imaging"},{"issue":"2","key":"10.1016\/j.psychres.2020.113409_bib0100","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/hipo.20902","article-title":"Cooperation between cholinergic and glutamatergic receptors are essential to induce BDNF-dependent long-lasting memory storage","volume":"22","author":"Navakkode","year":"2012","journal-title":"Hippocampus"},{"issue":"3","key":"10.1016\/j.psychres.2020.113409_bib0101","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3233\/JAD-2012-121447","article-title":"Modulation of \u03b17 nicotinic acetylcholine receptor and fibrillar amyloid-\u03b2 interactions in Alzheimer's disease brain","volume":"33","author":"Ni","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.psychres.2020.113409_bib0102","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.bbr.2016.07.023","article-title":"The combination of memantine and galantamine improves cognition in rats: the synergistic role of the \u03b17 nicotinic acetylcholine and NMDA receptors","volume":"313","author":"Nikiforuk","year":"2016","journal-title":"Behav. Brain Res."},{"issue":"9","key":"10.1016\/j.psychres.2020.113409_bib0103","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1523\/JNEUROSCI.5712-09.2010","article-title":"Prefrontal beta2 subunit-containing and alpha7 nicotinic acetylcholine receptors differentially control glutamatergic and cholinergic signaling","volume":"30","author":"Parikh","year":"2010","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.psychres.2020.113409_bib0104","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.biopsych.2019.01.006","article-title":"Synapse-to-Nucleus Signaling in Neurodegenerative and Neuropsychiatric Disorders","volume":"86","author":"Parra-Damas","year":"2019","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2020.113409_bib0105","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12974-020-1721-z","article-title":"Effects of inflammation on the kynurenine pathway in schizophrenia - a systematic review","volume":"17","author":"Pedraz-Petrozzi","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.psychres.2020.113409_bib0106","unstructured":"Perkins D.O., Jeffries C.D., Do K.Q., Potential roles of redox dysregulation in the development of schizophrenia, biological psychiatry, in press."},{"issue":"6","key":"10.1016\/j.psychres.2020.113409_bib0107","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s12603-012-0062-8","article-title":"A combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCI","volume":"16","author":"Peters","year":"2012","journal-title":"J. Nutr. Health Aging"},{"issue":"3","key":"10.1016\/j.psychres.2020.113409_bib0108","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.trci.2015.10.001","article-title":"Combined treatment with memantine and galantamine-CR compared with galantamine-CR only in antidementia drug na\u00efve patients with mild-to-moderate Alzheimer's Disease","volume":"1","author":"Peters","year":"2015","journal-title":"Alzheimers Dement. (N Y)"},{"issue":"6","key":"10.1016\/j.psychres.2020.113409_bib0109","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1007\/s00213-020-05495-y","article-title":"Activation of alpha7 nicotinic and NMDA receptors is necessary for performance in a working memory task","volume":"237","author":"Phenis","year":"2020","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.psychres.2020.113409_bib0110","first-page":"423","article-title":"Astrocytes as pharmacological targets in the treatment of schizophrenia: focus on kynurenic acid","volume":"23","author":"Pocivavsek","year":"2016"},{"issue":"8","key":"10.1016\/j.psychres.2020.113409_bib0111","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1038\/npp.2010.39","article-title":"Reduction of endogenous kynurenic acid formation enhances extracellular glutamate, hippocampal plasticity, and cognitive behavior","volume":"35","author":"Potter","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.psychres.2020.113409_bib0112","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3390\/molecules21040466","article-title":"Navigating the chemical space of multitarget-directed ligands: from hybrids to fragments in Alzheimer\u2019s Disease","volume":"21","author":"Prati","year":"2016","journal-title":"Molecules"},{"issue":"13","key":"10.1016\/j.psychres.2020.113409_bib0113","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1001\/jama.2019.2000","article-title":"Association of amyloid positron emission tomography with subsequent change in clinical management among medicare beneficiaries with mild cognitive impairment or dementia","volume":"321","author":"Rabinovici","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.psychres.2020.113409_bib0114","doi-asserted-by":"crossref","first-page":"33172","DOI":"10.1038\/srep33172","article-title":"In vivo characterization of ARN14140, a memantine\/galantamine-based multi-target compound for Alzheimer's Disease","volume":"6","author":"Reggiani","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.psychres.2020.113409_bib0115","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejmech.2019.07.011","article-title":"Merging memantine and ferulic acid to probe connections between NMDA receptors, oxidative stress and amyloid-\u03b2 peptide in Alzheimer's disease","volume":"180","author":"Rosini","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.psychres.2020.113409_bib0116","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.sbi.2008.09.009","article-title":"Curiosity to kill the KAT (kynurenine aminotransferase): structural insights into brain kynurenic acid synthesis","volume":"18","author":"Rossi","year":"2008","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.psychres.2020.113409_bib0117","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fped.2014.00087","article-title":"The use of medications approved for Alzheimer's disease in autism spectrum disorder: a systematic review","volume":"2","author":"Rossignol","year":"2014","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.psychres.2020.113409_bib0118","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.freeradbiomed.2019.09.014","article-title":"Early administration of galantamine from preplaque phase suppresses oxidative stress and improves cognitive behavior in APPswe\/PS1dE9 mouse model of Alzheimer's disease","volume":"145","author":"Saito","year":"2019","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.psychres.2020.113409_bib0119","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.expneurol.2005.07.004","article-title":"Endogenous kynurenate controls the vulnerability of striatal neurons to quinolinate: implications for Huntington\u2019s disease","volume":"197","author":"Sapko","year":"2006","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.psychres.2020.113409_bib0120","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41380-019-0414-4","article-title":"The kynurenine pathway: a finger in every pie","volume":"25","author":"Savitz","year":"2020","journal-title":"Mol. Psychiatry"},{"issue":"9","key":"10.1016\/j.psychres.2020.113409_bib0121","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/gim.2014.9","article-title":"Nicotinic acetylcholine receptors in human genetic disease","volume":"16","author":"Schaaf","year":"2014","journal-title":"Genet. Med."},{"issue":"1","key":"10.1016\/j.psychres.2020.113409_bib0122","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/sj.npp.1301087","article-title":"Galantamine enhances dopaminergic neurotransmission in vivo via allosteric potentiation of nicotinic acetylcholine receptors","volume":"32","author":"Schilstr\u00f6m","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.psychres.2020.113409_bib0123","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.neurobiolaging.2012.10.020","article-title":"Effects of memantine and galantamine on cognitive performance in aged rhesus macaques","volume":"34","author":"Schneider","year":"2013","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.psychres.2020.113409_bib0124","first-page":"251","article-title":"Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to","volume":"275","author":"Schneider","year":"2014","journal-title":"J. Intern. Med. 2014"},{"issue":"6101","key":"10.1016\/j.psychres.2020.113409_bib0125","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1126\/science.1228541","article-title":"Preventing Alzheimer\u2019s disease","volume":"337","author":"Selkoe","year":"2012","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.psychres.2020.113409_bib0126","article-title":"Exploring biomarkers for Alzheimer's Disease","volume":"10","author":"Sharma","year":"2016","journal-title":"J. Clin. Diagn. Res."},{"issue":"1","key":"10.1016\/j.psychres.2020.113409_bib0127","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4161\/cc.23067","article-title":"Early detection of neurodegenerative diseases: circulating brain-enriched microRNA","volume":"12","author":"Sheinerman","year":"2013","journal-title":"Cell Cycle"},{"key":"10.1016\/j.psychres.2020.113409_bib0128","series-title":"Roles of Nicotinic Acetylcholine Receptors in the Pathology and Treatment of Alzheimer's and Parkinson's Diseases. Nicotinic Acetylcholine Receptor Signaling in Neuroprotection","author":"Shimohama","year":"2018"},{"issue":"22","key":"10.1016\/j.psychres.2020.113409_bib0129","doi-asserted-by":"crossref","first-page":"9708","DOI":"10.1021\/jm3009458","article-title":"Combining galantamine and memantine in multitargeted, new chemical entities potentially useful in Alzheimer's disease","volume":"55","author":"Simoni","year":"2012","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.psychres.2020.113409_bib0130","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1021\/acs.molpharmaceut.9b00252","article-title":"Controlled Iontophoretic Delivery in Vitro and in Vivo of ARN14140-A Multitarget Compound for Alzheimer's Disease","volume":"16","author":"Singhal","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.psychres.2020.113409_bib0131","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ajp.2017.01.002","article-title":"Caregiver burden in Alzheimer-type dementia and psychosis: a comparative study from India","volume":"26","author":"Sinha","year":"2017","journal-title":"Asian J Psychiatr"},{"key":"10.1016\/j.psychres.2020.113409_bib0132","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.neuropharm.2015.02.006","article-title":"The human CHRNA7 and CHRFAM7A genes: a review of the genetics, regulation, and function","volume":"96","author":"Sinkus","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.psychres.2020.113409_bib0133","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2009.07.041","article-title":"A 2-base pair deletion polymorphism in the partial duplication of the alpha7 nicotinic acetylcholine gene (CHRFAM7A) on chromosome 15q14 is associated with schizophrenia","volume":"1291","author":"Sinkus","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.psychres.2020.113409_bib0134","doi-asserted-by":"crossref","unstructured":"Sobrado M., Roda J.M., L\u00f3pez M.G., Egea J., Garc\u00eda A.G. Neurosci Lett. 2004Jul 22;365(2):132\u20136. Galantamine and memantine produce different degrees of neuroprotection in rat hippocampal slices subjected to oxygen-glucose deprivation.","DOI":"10.1016\/j.neulet.2004.04.067"},{"issue":"3","key":"10.1016\/j.psychres.2020.113409_bib0135","doi-asserted-by":"crossref","first-page":"295","DOI":"10.31887\/DCNS.2006.8.3\/mspedding","article-title":"New directions for drug discovery","volume":"8","author":"Spedding","year":"2006","journal-title":"Dialogues Clin. Neurosci."},{"issue":"2","key":"10.1016\/j.psychres.2020.113409_bib0136","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s11682-018-9967-0","article-title":"The application of positron emission tomography (PET) imaging in CNS drug development","volume":"13","author":"Suridjan","year":"2019","journal-title":"Brain Imaging Behav."},{"issue":"1","key":"10.1016\/j.psychres.2020.113409_bib0137","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13550-017-0313-0","article-title":"A human PET study of [11C]HMS011, a potential radioligand for AMPA receptors","volume":"7","author":"Takahata","year":"2017","journal-title":"EJNMMI Res."},{"issue":"51","key":"10.1016\/j.psychres.2020.113409_bib0138","doi-asserted-by":"crossref","first-page":"40180","DOI":"10.1074\/jbc.M110.142356","article-title":"Galantamine-induced amyloid-{beta} clearance mediated via stimulation of microglial nicotinic acetylcholine receptors","volume":"285","author":"Takata","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.psychres.2020.113409_bib0139","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25030564","article-title":"Are kynurenines accomplices or principal villains in dementia? maintenance of kynurenine metabolism","volume":"25","author":"Tanaka","year":"2020","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.psychres.2020.113409_bib0140","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s43440-020-00067-5","article-title":"Antidepressant-like effects of kynurenic acid in a modified forced swim test","volume":"72","author":"Tanaka","year":"2020","journal-title":"Pharmacol. Rep."},{"issue":"2","key":"10.1016\/j.psychres.2020.113409_bib0141","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192498","article-title":"Role of \u03b17nAChR-NMDAR in sevoflurane-induced memory deficits in the developing rat hippocampus","volume":"13","author":"Tang","year":"2018","journal-title":"PLoS ONE"},{"issue":"17","key":"10.1016\/j.psychres.2020.113409_bib0142","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1111\/bph.14744","article-title":"\u03b17 nicotinic ACh receptors are necessary for memory recovery and neuroprotection promoted by attention training in amyloid-\u03b2-infused mice","volume":"176","author":"Telles-Longui","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.psychres.2020.113409_bib0143","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.neuroscience.2011.08.038","article-title":"Glutamate and nicotinic receptor interactions in working memory: importance for the cognitive impairment of schizophrenia","volume":"195","author":"Timofeeva","year":"2011","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.psychres.2020.113409_bib0144","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/mds.26428","article-title":"Combination therapies: the next logical Step for the treatment of synucleinopathies?","volume":"31","author":"Valera","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.psychres.2020.113409_bib0145","doi-asserted-by":"crossref","first-page":"943","DOI":"10.3389\/fphar.2019.00943","article-title":"The Concentration of Memantine in the Cerebrospinal Fluid of Alzheimer's Disease Patients and Its Consequence to Oxidative Stress Biomarkers","volume":"10","author":"Valis","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"6. Vyp. 2","key":"10.1016\/j.psychres.2020.113409_bib0146","doi-asserted-by":"crossref","first-page":"32","DOI":"10.17116\/jnevro201811806232","article-title":"The addition of memantine to galantamine increases treatment efficacy in patients with moderate dementia with Lewy bodies","volume":"118","author":"Vasenina","year":"2018","journal-title":"Zh Nevrol Psikhiatr Im S Korsakova"},{"key":"10.1016\/j.psychres.2020.113409_bib0147","unstructured":"Vishwas S., Awasthi A., Corrie L., Singh S.K., Gulati M. Multiple target-based combination therapy of galantamine, memantine and lycopene for the possible treatment of Alzheimer's Disease. Med. Hypotheses, in press."},{"issue":"5","key":"10.1016\/j.psychres.2020.113409_bib0148","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1460-9568.2006.04645.x","article-title":"Reparatory effects of nicotine on NMDA receptor-mediated synaptic plasticity in the hippocampal CA1 region of chronically lead-exposed rats","volume":"23","author":"Wang","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.psychres.2020.113409_bib0149","doi-asserted-by":"crossref","first-page":"9493","DOI":"10.1038\/srep09493","article-title":"The modulation of nicotinic acetylcholine receptors on the neuronal network oscillations in rat hippocampal CA3 area","volume":"5","author":"Wang","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.psychres.2020.113409_bib0150","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.neulet.2017.10.022","article-title":"Postnatal administration of memantine rescues TNF-\u03b1-induced decreased hippocampal precursor proliferation","volume":"662","author":"Wang","year":"2018","journal-title":"Neurosci. Lett."},{"issue":"7","key":"10.1016\/j.psychres.2020.113409_bib0152","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/ijnp\/pyy021","article-title":"Brain PET Imaging of \u03b17-nAChR with [18F]ASEM: reproducibility, Occupancy, Receptor Density, and Changes in Schizophrenia","volume":"21","author":"Wong","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.psychres.2020.113409_bib0153","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/schbul\/sbq002","article-title":"Cortical kynurenine pathway metabolism: a novel target for cognitive enhancement in Schizophrenia","volume":"36","author":"Wonodi","year":"2010","journal-title":"Schizophr. Bull."},{"issue":"6","key":"10.1016\/j.psychres.2020.113409_bib0154","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/sj.npp.1301259","article-title":"Preclinical investigation of the functional effects of memantine and memantine combined with galantamine or donepezil","volume":"32","author":"Woodruff-Pak","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2020.113409_bib0156","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jprot.2015.10.018","article-title":"Cross-talk between \u03b17 nAchR and NMDAR revealed by protein profiling","volume":"131","author":"Zhang","year":"2016","journal-title":"J. Proteomics"},{"issue":"7\u20138","key":"10.1016\/j.psychres.2020.113409_bib0157","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.neuropharm.2006.08.007","article-title":"In vitro galantamine-memantine co-application: mechanism of beneficial action","volume":"51","author":"Zhao","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.psychres.2020.113409_bib0158","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.schres.2019.05.019","article-title":"Adjunctive memantine for major mental disorders: a systematic review and meta-analysis of randomized double-blind controlled trials","volume":"209","author":"Zheng","year":"2019","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.psychres.2020.113409_bib0159","doi-asserted-by":"crossref","first-page":"390","DOI":"10.5607\/en.2019.28.3.390","article-title":"Memantine improves cognitive function and alters hippocampal and cortical proteome in triple transgenic mouse model of Alzheimer's Disease","volume":"28","author":"Zhou","year":"2019","journal-title":"Exp. Neurobiol."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178120325518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178120325518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T05:44:05Z","timestamp":1759038245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178120325518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":156,"alternative-id":["S0165178120325518"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2020.113409","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Galantamine-Memantine combination in the treatment of Alzheimer's disease and beyond","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2020.113409","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113409"}}